Taiyen Biotech Co Ltd
TWSE:1737

Watchlist Manager
Taiyen Biotech Co Ltd Logo
Taiyen Biotech Co Ltd
TWSE:1737
Watchlist
Price: 31.6 TWD -0.32% Market Closed
Market Cap: 6.3B TWD

Wall Street
Price Targets

Price Targets Summary
Taiyen Biotech Co Ltd

There are no price targets for Taiyen Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Taiyen Biotech Co Ltd Competitors:
Price Targets
SALME
Salmon Evolution ASA
51% Upside
BELL
Bell Food Group AG
37% Upside
HUPSENG
Hup Seng Industries Bhd
6% Downside
NESTLE
Nestle (Malaysia) Bhd
6% Downside
ULTJ
Ultrajaya Milk Industry Tbk PT
56% Upside
002507
Chongqing Fuling Zhacai Group Co Ltd
11% Upside
BYND
Beyond Meat Inc
203% Upside
71N
Nissui Corp
18% Upside

Revenue
Forecast

Revenue Estimate
Taiyen Biotech Co Ltd

Revenue forecast
is not available for
Taiyen Biotech Co Ltd

Operating Income
Forecast

Operating Income Estimate
Taiyen Biotech Co Ltd

For the last 13 years the compound annual growth rate for Taiyen Biotech Co Ltd's operating income is 3%. The projected CAGR for the next 9 years is 0%.

3%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Taiyen Biotech Co Ltd

For the last 13 years the compound annual growth rate for Taiyen Biotech Co Ltd's net income is 5%. The projected CAGR for the next 9 years is -1%.

5%
Past Growth
-1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Taiyen Biotech Co Ltd's stock price target?
Not Available

Taiyen Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Taiyen Biotech Co Ltd's Operating Income forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Taiyen Biotech Co Ltd's operating income is 3%. The projected CAGR for the next 9 years is 0%.

What is Taiyen Biotech Co Ltd's Net Income forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Taiyen Biotech Co Ltd's net income is 5%. The projected CAGR for the next 9 years is -1%.

Back to Top